Prevalence and Clinical Implications of COVID-19 Myocarditis

The clinical manifestations of COVID-19 are widely variable and may involve several districts. Although the clinical course is mostly characterized by respiratory involvement, up to 30% of hospitalized patients have evidence of myocardial injury due to acute coronary syndrome, cardiac arrhythmias, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Chimenti, Cristina, Magnocavallo, Michele, Ballatore, Federico, Bernardini, Federico, Alfarano, Maria, Della Rocca, Domenico G., Severino, Paolo, Lavalle, Carlo, Francesco, Fedele, Frustaci, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576114/
https://www.ncbi.nlm.nih.gov/pubmed/35221085
http://dx.doi.org/10.1016/j.ccep.2021.11.001
Descripción
Sumario:The clinical manifestations of COVID-19 are widely variable and may involve several districts. Although the clinical course is mostly characterized by respiratory involvement, up to 30% of hospitalized patients have evidence of myocardial injury due to acute coronary syndrome, cardiac arrhythmias, myocarditis, and cardiogenic shock. In particular, myocarditis is a well-recognized severe complication of COVID-19 and is associated with fulminant cardiogenic shock and sudden cardiac death. In this article, the authors aim to present a comprehensive review about COVID-19–related myocarditis, including clinical characteristics, diagnostic workup, and management.

Ejemplares similares